WCN24-1486 ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES - Natallia Maroz; Ashantice Higgins; John Harcha; Kelsey Marshall; Derek Jernigan (Kidney International Reports)